31-May-2023
English, PDF, 682kb
From alternative protein sources to rapid vaccine development, synthetic biology can address global challenges and transform industries. But are current governance frameworks up to the task?
26-April-2023
English
4-November-2022
English
Indicators include nanotech firms, nanotech R&D, public sector R&D expenditure and nanotechnology patents.
4-November-2022
English
Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.
12-April-2022
English
6-December-2021
English
This conference on 6-7 December seeks to develop a policy agenda to pair the transformative potential of emerging technology with the necessity of good governance: how we can innovate more and innovate better, i.e. within inclusive processes with values at the centre and lasting positive impact.
9-November-2021
English
Major breakthroughs in neurotechnology have the potential to advance biomedicine and healthcare, but uncertainty exists about the impact and direction of these developments. This round table on 9 November, co-organised by the Council of Europe, will discuss human rights issues raised by the applications of neurotechnologies.
19-May-2021
English
This workshop on 19-20 May 2021 focused on enabling societal deliberation on neurotechnology and promoting cultures of stewardship and trust in neurotechnology across the public and private sector in the context of the OECD Recommendation on Responsible Innovation in Nanotechnology.
23-April-2021
English
1-March-2021
English